Interferon-γ and tumor necrosis factor-α specifically induce formation of cytomegalovirus-permissive monocyte-derived macrophages that are refractory to the antiviral activity of these cytokines

Journal of Clinical Investigation

Volumn 100, Issue 12, 1997, Pages 3154-3163

  Söderberg Nauclér, Cecilia ^a,b   Fish, Kenneth N ^a   Nelson, Jay A ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b Novum   (Sweden)

Author keywords

Cytomegalovirus; Differentiation; Interferon; Macrophages; Tumour necrosis factor

Indexed keywords

CD19 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 2; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANTIVIRAL ACTIVITY; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; VIRUS REPLICATION;

EID: 0242504922     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119871     Document Type: Article

References (57)

1. Chou, S.W. 1986. Acquisition of donor strains of cytomegalovirus by renal-transplant recipients. N. Engl. J. Med. 314(22):1418-1423.
2. Chou, S., D.Y. Kim, and D.J. Norman. 1987. Transmission of cytomegalovirus by pretransplant leukocyte transfusions in renal transplant candidates. J. Infect. Dis. 155(3):565-567.
3. Chou, S. 1987. Cylomegalovirus infection and re-infection transmitted by heart transplantation. 155:1054-1056.
4. Chou, S.W. 1989. Reactivation and recombination of multiple cytomegalovirus strains from individual organ donors. J. Infect. Dis. 160(1):11-15.
5. Tegtmeier, G.E. 1986. Cytomegalovirus infection as a complication of blood transfusion. Semin. Liver Dis. 6(1):82-95.
6. Meyers, J.D., N. Flournoy, and E.D. Thomas. 1986. Risk factors for cytomegalovirus infection after human marrow transplantation. J. Infect. Dis. 153(3):478-488.
7. Gnann, J. Jr., J. Ahlmen, C. Svalander, L. Olding, M.B. Oldstone, and J.A. Nelson. 1988. Inflammatory cells in transplanted kidneys are infected by human cytomegalovirus. Am. J. Pnthol. 132(2):239-248.
8. Sinzger, C., B. Plachter, S. Stenglein, and G. Jahn. 1993. Immunohistochemical detection of viral antigens in smooth muscle, stromal, and epithelial cells from acute human cytomegalovirus gastritis. J. Infect. Dis. 167(6):1427-1432.
9. Söderberg, C., S. Larsson, S. Bergstedt-Lindqvisl, and E. Möller. 1993. Definition of a subset of human peripheral blood mononuclear cells that are permissive to human cytomegalovirus infection. J. Virol. 67(6):3166-3175.
10. Link, H., K. Battmer, and C. Stumme. 1993. Cytomegalovirus infection in leucocytes after bone marrow transplantation demonstrated by mRNA in situ hybridization. Br. J. Haematol. 85(3):573-577.
11. von Laer, D., A. Serr, U. Meyer-Konig, G. Kirste, F.T. Hufert, and O. Haller. 1995. Human cytomegalovirus immediate early and late transcripts are expressed in all major leukocyte populations in vivo. J. Infect. Dis. 172(2):365-370.
12. Taylor-Wiedeman, J., J.G. Sissons, L.K. Borysiewicz, and J.H. Sinclair. 1991. Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J. Gen. Virol. 72(9):2059-2064.
13. Dankner, W.M., J.A. McCutchan, D.D. Richman, K. Hirata, and S.A. Spector. 1990. Localization of human cytomegalovirus in peripheral blood leukocytes by in situ hybridization. J. Infect. Dis. 161(1):31-36.
14. Taylor-Wiedeman, J., P. Sissons, and J. Sinclair. 1994. Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers. J. Virol. 68(3):1597-1604.
15. Sinzger, C., H. Muntefering, T. Loning, H. Sloss, B. Plachter, and G. Jahn. 1993. Cell types infected in human cytomegalovirus placentitis identified by immunohistochemical double staining. Virchows Arch A Pathol. Anal. Histopathol. 423(4):249-256.
16. Minton, E.J., C. Tysoe, J.H. Sinclair, and J.G. Sissons. 1994. Human cytomegalovirus infection of the monocyte/macrophage lineage in bone marrow. J. Virol. 68(6):4017-4021.
17. Ibanez, C.E., R. Schrier, P. Ghazal, C. Wiley, and J.A. Nelson. 1991. Human cytomegalovirus productively infects primary differentiated macrophages. J. Virol. 65(12):6581-6588.
18. Maciejewski, J.P., E.E. Bruening, R.E. Donahue, S.E. Sellers, C. Carter, N.S. Young, and S. St. Jeor. 1993. Infection of mononucleated phagocytes with human cytomegalovirus. Virology. 195(2):327-336.
19. Weinshenker, B.G., S. Wilton, and G.P. Rice. 1988. Phorbol ester-induced differentiation permits productive human cytomegalovirus infection in a monocytic cell line. J. Immunol. 140(5):1625-1631.
20. Lathey, J.L., and S.A. Spector. 1991. Unrestricted replication of human cytomegalovirus in hydrocortisone-treated macrophages. J. Virol. 65(11):6371-6375.
21. Sinclair, J.H., J. Baillie, L.A. Bryant, J.A. Taylor-Wiedeman, and J.G. Sissons. 1992. Repression of human cytomegalovirus major immediate early gene expression in a monocytic cell line. J. Gen. Virol. 73(2):433-135.
22. Fish, K.N., S.G. Stenglein, C. Ibanez, and J.A. Nelson. 1995. Cytomegalovirus persistence in macrophages and endothelial cells. Scand. J. Inf. Dis. Suppl. 99:34-40.
23. Kondo, K., H. Kaneshima, and E.S. Mocarski. 1994. Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. PNAS USA. 91(25):11879-11883.
24. Kondo K., J. Xu, and E.S. Mocarski. 1996. Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in J seropositive individuals. Pror. Natl. Acad. Sci. USA. 93(20):11137-11142.
25. Stenberg, R.M., A.S. Depto, J. Fortney, and J.A. Nelson. 1989. Regulaled expression of early and late RNAs and proteins from the human cytomegalovirus immediate-early gene region. J. Virol. 63(6):2699-2708.
26. Britt, W.J., and L.G. Vugler. 1992. Oligomerization of the human cytomegalovirus major envelope glycoprotein complex gB (gp55-116). J. Virol. 66(11):6747-6754.
27. Wentworth, B.B., and L. French. 1970. Plaque assay of cytomegalovirus strains of human origin. Proc. Soc. Exp. Biol. Med. 135(2):253-258.
28. Boros, D.L. 1978. Granulomatous inflammations. Prog. Allergy. 24:183-267.
29. Adams, D.O. 1976. The granulomatous inflammatory response. A review, Am. J. Pathol. 84(1):164-191.
30. Adams, D., and T.A. Hamilton. 1992. Molecular basis of macrophage activation: diversity and its origin. In The Macrophage. C.E. Lewis and J.O'D. McGee, editors. Oxford University Press, Oxford. 77-115.
31. Weinberg, J.B., M.M. Hobbs, and M.A. Misukonis. 1984. Recombinant human gamma-interferon induces human monocyte polykaryon formation. PNAS USA. 81(14):4554-4557.
32. Weinberg, J.B., M.M. Hobbs, and M.A. Misukonis. 1985. Phenotypic characterization of gamma interferon-induced human monocyte polykaryons. Blood. 66(6):1241-1246.
33. Postlethwaite, A.E., B.K. Jackson, E.H. Beachey, and A.H. Kang. 1982. Formation of multinucleated giant cells from human monocyte precursors. Mediation by a soluble protein from antigen-and mitogen-stimulated lymphocytes. J. Exp. Med. 155(1):168-178.
34. Abe, E., Y. Ishimi, C.H. Jin, M.H. Hong, T. Sato, and T. Suda. 1991. Granulocyte-macrophage colony-stimulating factor is a major macrophage fusion factor present in conditioned medium of concanavalin A-stimulated spleen cell cultures. J. Immunol. 147(6):1810-1815.
35. McInnes. A., and D.M. Rennick. 1988. Interleukin 4 induces cultured monocytes/macrophages to form giant multinucleated cells. J. Exp. Med. 167(2):598-611.
36. Gu, J.J., J.V. Harriss, K. Ozato, and P.D. Gottlieb. 1994. Induction by concanavalin A of specific mRNAs and cytolytic function in a CD8-positive T cell hybridoma. J. Immunol. 153(10):440-417.
37. Sitkovsky, M.V., M.S. Pasternack, J.P. Lugo, J.R. Klein, and H.N. Eisen. 1984. Isolation and partial characterization of concanavalin A receptors on cloned cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA. 81(5):1519-1523.
38. Klein, J.R., D.H. Raulet, M.S. Pasternack, and M.J. Bevan. 1982. Cytotoxic T lymphocytes produce immune interferon in response to antigen or mitogen. J. Exp. Med. 155(4):1198-1203.
39. Sitkovsky, M.V., M.S. Pasternack, and H.N. Eisen. 1982. Inhibition of cytotoxic T lymphocyte activity by concanavalin A. J. Immunol. 129(4):1372-1376.
40. Klein, J.R., M.S. Pasternack, and M.J. Bevan. 1985. Activation requirements for antigen- and mitogen-induced interferon-gamma release from cytotoxic T lymphocytes. J. Immunol. 134(4):2456-2461.
41. Leist, T.P., M. Eppler, and R.M. Zinkernagel. 1989. Enhanced virus replication and inhibition of lymphocytic choriomeningitis virus disease in antigamma interferon-treated mice. J. Virol. 63(6):2813-2319.
42. Huang, S., W. Hendriks, A. Althage, S. Hemmi, H. Bluethmann, R. Kamijo, J. Vilcek, R.M. Zinkernagel, and M. Aguet. 1993. Immune response in mice that lack the interferon-gamma receptor. Science. 259(5102):1742-1745.
43. Stanton, G.J., C. Jordan, A. Hart, H. Heard, M.P. Langford, and S. Baron. 1987. Nondetectable levels of interferon gamma is a critical host defense during the first day of herpes simplex virus infection. Microb. Pathog. 3(3):179-183.
44. Koyanagi Y., W.A. O'Brien, J.Q. Zhao, D.W. Golde, J.C. Gasson, and I.S. Chen. 1988. Cytokines alter production of HIV-1 from primary mononuclear phagocytes. Science. 241(4873):1673-1675.
45. Kornbluth, R.S., P.S. Oh, J.R. Munis, P.H. Cleveland, and D.D. Richman. 1989. Interferons and bacterial lipopolysaccharide protect macrophages from productive infection hy human immunodeficiency virus in vitro. J. Exp. Med 169(3):1137-1151.
46. Meylan, P.R., J.C. Gualelli, J.R. Munis, D.D. Richman, and R.S. Kornbluth. 1993. Mechanisms for the inhibition of HIV replication by interferons-alpha, -beta, and -gamma in primary human macrophages. Virology. 193(1): 138-148.
47. Peterson, P.K., G. Gekker, C.C. Chao, S.X. Hu, C. Edelman, H.H. Balfour, and J. Verhoef. 1992. Human cytomegalovirus-stimulated peripheral blood mononuclear cells induce HIV-1 replication via a tumor necrosis faclor-alpha-mediated mechanism. J. Clin. Invest. 89(2):574-580.
48. Heise, M.T., and H.W. Virgin 4th. 1995. The T-cell-independent role of gamma interferon and tumor necrosis factor alpha in macrophage activation during murine cytomegalovirus and herpes simplex virus infections. J Virol. 69(2):904-909.
49. Davignon, J.L., P. Castanie, J.A. Yorke, N. Gautier, D. Clement, and C. Davrinche. 1996. Anti-human cytomegalovirus activity of cytokines produced hy CD41 T-cell clones specifically activated by IE1 peptides in vitro. J. Virol. 70(4):2162-2169.
50. Schut, R.L., G. Gekker, S. Hu, C.C. Chao, C. Pomeroy, M.C. Jordan, and P.K. Peterson. 1994. Cytomegalovirus replication in murine microglial cell cultures: suppression of permissive infection by interferon-gamma. J. Infect. Dis. 169(5):1092-1096.
51. Lucin, P., S. Jonjic, M. Messerle, B. Polie, H. Hengel, and U.H. Koszinowski. 1994. Late phase inhibition of murine Cytomegalovirus replication by synergistic action of interferon-gamma and tumour necrosis factor. J. Gen. Virol. 75(1):101-110.
52. Pavic, I., B. Polic, I. Crnkovic, P. Lucin, S. Jonjic, and U.H. Koszinowski. 1993. Participation of endogenous tumour necrosis factor alpha in host resistance to Cytomegalovirus infection. J. Gen. Virol. 74(10):2215-2223.
53. Fennie, E.H., Y.S. Lie, M.A. Low, P. Gribling, and K.P. Anderson. 1988. Reduced mortality in murine Cytomegalovirus infected mice following prophylactic murine interferon-gamma treatment. Antivir. Res. 10(1-3):27-39.
54. Biswas, P., G. Poli, A.L. Kinter, J.S. Justement, S.K., Stanley, W.J. Maury, P. Bressler, J.M. Orenstein, and A.S. Fauci. 1992. Interferon gamma induces the expression of human immunodeficiency virus in persistently infected promonocytic cells (U1) and redirects the production of virions to intracytoplasmic vacuoles in phorbol myristate acetate-differentiated U1 cells. J. Exp. Med. 176(3):739-750.
55. Haagmans, B.L., P.H. van der Meide, F.S. Stals, A.J. van den Eertwegh, E. Claassen, C.A. Bruggeman, M.C. Horzinek and V.E. Schijns. 1994. Suppression of rat Cytomegalovirus replication by antibodies against gamma interferon. J. Virol. 68(4):2305-2312.
56. Haagmans, B.L., F.S. Stals, P.H. van der Meide, C.A. Bruggeman, M.C. Horzinek, and V.E. Schijns. 1994. Tumor necrosis factor alpha promotes replication and pathogenicity of rat Cytomegalovirus. J. Virol. 68(4):2297-2304.
57. Stein, J., H.D. Volk, C. Liebenthal, D.H. Kruger, and S. Prosch. 1993. Tumour necrosis factor alpha stimulates the activity of the human Cytomegalovirus major immediate early enhancer/promoter in immature monocytic cells. J. Gen. Virol. 74(11):2333-2338.